Income Statement
PROCEPT BIOROBOTICS CORP
PRCT
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Revenue
|
308.05 | 224.50 | 136.19 | 75.01 | 34.47 |
|
Cost of Revenue
|
111.83 | 87.40 | 65.14 | 37.93 | 18.61 |
|
Gross Profit
|
196.23 | 137.10 | 71.05 | 37.09 | 15.87 |
|
Operating Expenses
|
300.09 | 233.71 | 180.22 | 117.81 | 70.03 |
|
Research & Development
|
71.28 | 62.30 | 48.45 | 28.98 | 18.99 |
|
Selling, General & Administrative
|
228.81 | 171.42 | 131.77 | 88.83 | 51.04 |
|
Other Operating Expenses
|
- | - | - | - | - |
|
Operating Income
|
-103.86 | -96.61 | -109.17 | -80.72 | -54.16 |
|
Non-Operating Income
|
-8.48 | - | - | - | - |
|
Interest Income
|
12.22 | 10.90 | 7.55 | 2.50 | 0.08 |
|
Interest Expense
|
- | - | 4.00 | 5.18 | 5.81 |
|
Other Non-Op Income / Expense
|
-0.16 | -1.40 | -0.18 | -0.20 | -0.15 |
|
Income Before Tax
|
-95.38 | - | - | - | - |
|
Income Tax Expense
|
0.19 | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - |
|
Net Income
|
-95.57 | -91.41 | -105.90 | -87.15 | -59.85 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - |
|
EBITDA
|
-97.47 | -91.38 | -109.17 | -77.88 | -50.84 |
|
Earnings Per Share (Basic)
|
-1.72 | -1.75 | -2.24 | -1.96 | -3.63 |
|
Diluted EPS
|
-1.72 | -1.75 | -2.24 | -1.96 | -3.63 |
|
Weighted Average Shares
|
55.54 | 52.13 | 47.26 | 44.40 | 16.48 |
|
Diluted Weighted Avg Shares
|
55.54 | 52.13 | 47.26 | 44.40 | 16.48 |
|
Comprehensive Income
|
-95.65 | -91.38 | -105.81 | -87.11 | -59.89 |